Latest California Healthline Stories
As Holdout Missouri Joins Nation in Monitoring Opioid Prescriptions, Experts Worry
Missouri is the last state to create a monitoring program to help spot the misuse of prescription drugs. But some public health experts warn that the nation’s programs are forcing people addicted to opioids to seek deadlier street options.
KHN’s ‘What the Health?’: Delta Changes the Covid Conversation
With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.
With a Diagnosis at Last, Black Women with ADHD Start Healing
Black women and girls with attention deficit hyperactivity disorder often remain undiagnosed because their symptoms are mischaracterized by the blinders of sexism and racism. Getting treatment and finding the right medication can be even more difficult because they aren’t taken seriously or, worse, they’re racially profiled while getting their medicines.
How ERs Fail Patients With Addiction: One Patient’s Tragic Death
Two intractable failings of the U.S. health care system — addiction treatment and medical costs — come to a head in the ER, where patients desperate for addiction treatment arrive, only to find the facility may not be equipped to deal with substance use or, if they are, treatment is prohibitively expensive.
Why We May Never Know Whether the $56,000-a-Year Alzheimer’s Drug Actually Works
It could take years for follow-up studies to prove Aduhelm slows the disease — or doesn’t. Meanwhile, its maker will profit.
Doctors Weigh Pros and Cons of Prescribing Hot-Button Alzheimer’s Drug
The potential benefits of Aduhelm are small, its effectiveness is not certain, and even the FDA Thursday shifted its guidance on who should get the drug. But physicians are dealing with an onslaught of interest from patients and their families, and figuring out which patients are best positioned to be helped by the drug will be difficult.
Doctores sopesan pros y contras de recetar la nueva droga para el Alzheimer
Mientras médicos y expertos en políticas de salud debaten los méritos de Aduhelm, el primer fármaco para el Alzheimer aprobado en 18 años, los pacientes simplemente quieren saber: “¿me ayudará?”.
A Family Wellness Check: California Invests in Treating Parents and Children Together
The state will be the first to offer comprehensive counseling services to parents during pediatric visits as part of Medicaid.
No Vacancy: How a Shortage of Mental Health Beds Keeps Kids Trapped Inside ERs
What’s known as emergency room boarding of psychiatric patients has risen between 200% and 400% monthly in Massachusetts during the pandemic — and the problem is widespread. The CDC says emergency room visits after suicide attempts among teen girls were up 51% earlier this year as compared with 2019.
A Break From Breathlessness: How Singing Helped Me Through Long Covid
Long before covid, music therapists used singing and wind instruments to help COPD and asthma patients. These same therapies might help patients recover from covid’s lingering symptoms as well. And though it wasn’t clinical music therapy, singing with an online choir has helped me navigate long covid.